Drugmakers Face More Scrutiny of Discordant U.S. Prices

Drug companies’ reliance on profits from exorbitant U.S. drug prices may cause the system to come crashing down as a result of competition from generic drugmakers that will likely prompt governments to clamp down on pharmaceutical budgets.
Reuters